Ramon V Cortez1, Carla R Taddei2, Luiz G Sparvoli2, Ana G S Ângelo1, Marina Padilha2, Rosiane Mattar1, Silvia Daher3. 1. Department of Obstetrics, Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo 669, 9 andar - 04939032, São Paulo, Brazil. 2. Department of Clinical and Toxicological Analysis, Universidade de São Paulo (USP), Av.Prof. Lineu Prestes 580- bloco 17- 05508000, São Paulo, Brazil. 3. Department of Obstetrics, Universidade Federal de São Paulo (UNIFESP), Rua Pedro de Toledo 669, 9 andar - 04939032, São Paulo, Brazil. silviadaher@hotmail.com.
Abstract
PURPOSE: Gestational diabetes mellitus (GDM), the major endocrine pathology in pregnancy, has been associated with the development of an intense inflammatory process and increased insulin resistance. The maternal microbiota is involved in several metabolic functions; however, its role in GDM physiopathology remains unclear. The aim of this study was to assess the composition of the microbiota at different sites and evaluate its relationship with the occurrence of GDM. METHODS: This cross-sectional study recruited women in the third trimester of gestation with and without GDM. Oral, vaginal, and stool samples were evaluated using next-generation sequencing. We included 68 participants: 26 with and 42 without GDM. RESULTS: The analysis of the oral microbiome did not show significant differences in phyla and genus among the studied groups. In contrast, GDM patients presented a specific vaginal and intestinal microbiome composition, which was less diverse than those found in the control group, showing genera related to dysbiosis. CONCLUSIONS: Our findings suggest that changes in the composition of the vaginal and intestinal microbiome might be involved in the development of GDM. The follow-up of these patients in order to evaluate vaginal and intestinal samples after delivery may contribute to understanding the development of metabolic disease in women with previous GDM.
PURPOSE:Gestational diabetes mellitus (GDM), the major endocrine pathology in pregnancy, has been associated with the development of an intense inflammatory process and increased insulin resistance. The maternal microbiota is involved in several metabolic functions; however, its role in GDM physiopathology remains unclear. The aim of this study was to assess the composition of the microbiota at different sites and evaluate its relationship with the occurrence of GDM. METHODS: This cross-sectional study recruited women in the third trimester of gestation with and without GDM. Oral, vaginal, and stool samples were evaluated using next-generation sequencing. We included 68 participants: 26 with and 42 without GDM. RESULTS: The analysis of the oral microbiome did not show significant differences in phyla and genus among the studied groups. In contrast, GDM patients presented a specific vaginal and intestinal microbiome composition, which was less diverse than those found in the control group, showing genera related to dysbiosis. CONCLUSIONS: Our findings suggest that changes in the composition of the vaginal and intestinal microbiome might be involved in the development of GDM. The follow-up of these patients in order to evaluate vaginal and intestinal samples after delivery may contribute to understanding the development of metabolic disease in women with previous GDM.
Authors: M Kilian; I L C Chapple; M Hannig; P D Marsh; V Meuric; A M L Pedersen; M S Tonetti; W G Wade; E Zaura Journal: Br Dent J Date: 2016-11-18 Impact factor: 1.626
Authors: A Santacruz; M C Collado; L García-Valdés; M T Segura; J A Martín-Lagos; T Anjos; M Martí-Romero; R M Lopez; J Florido; C Campoy; Y Sanz Journal: Br J Nutr Date: 2010-03-08 Impact factor: 3.718
Authors: Aurélie Cotillard; Sean P Kennedy; Ling Chun Kong; Edi Prifti; Nicolas Pons; Emmanuelle Le Chatelier; Mathieu Almeida; Benoit Quinquis; Florence Levenez; Nathalie Galleron; Sophie Gougis; Salwa Rizkalla; Jean-Michel Batto; Pierre Renault; Joel Doré; Jean-Daniel Zucker; Karine Clément; Stanislav Dusko Ehrlich Journal: Nature Date: 2013-08-29 Impact factor: 49.962
Authors: Sayyid Hasan; Velma Aho; Pedro Pereira; Lars Paulin; Saila B Koivusalo; Petri Auvinen; Johan G Eriksson Journal: Acta Obstet Gynecol Scand Date: 2018-01 Impact factor: 3.636
Authors: Kjersti Aagaard; Kevin Riehle; Jun Ma; Nicola Segata; Toni-Ann Mistretta; Cristian Coarfa; Sabeen Raza; Sean Rosenbaum; Ignatia Van den Veyver; Aleksandar Milosavljevic; Dirk Gevers; Curtis Huttenhower; Joseph Petrosino; James Versalovic Journal: PLoS One Date: 2012-06-13 Impact factor: 3.240
Authors: Zubaidah Hasain; Norfilza Mohd Mokhtar; Nor Azmi Kamaruddin; Nor Azlin Mohamed Ismail; Nurul Huda Razalli; Justin Vijay Gnanou; Raja Affendi Raja Ali Journal: Front Cell Infect Microbiol Date: 2020-05-15 Impact factor: 5.293